FDA Adds Warning on Risk for PE, Death With Higher-Dose Xeljanz - Medscape

FDA Adds Warning on Risk for PE, Death With Higher-Dose Xeljanz  Medscape

The FDA has approved new warnings on risk for blood clots and death with the 10-mg twice-daily dose of tofacitinib, based on data from an ongoing ...



Comments

Post a Comment

Popular posts from this blog

Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma - Global Banking And Finance Review

Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma    Global Banking And Finance Review Celgene Corporation (NASDAQ:CELG) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ...
Read more